BioSpace News Archive

FDA

GENFIT announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC

FDA grants elafibranor Breakthrough Therapy Designation, based on Phase 2 data, for treatment of PBC (Primary Biliary Cholangitis) in adults with inadequate response to UDCA

April 18, 2019
·
7 min read
Deals

Lonza Announces Results of the 2019 Annual General Meeting – All Motions Proposed by Board of Directors Accepted

312 shareholders attended, representing 60% of the issued share capital

April 18, 2019
·
3 min read
Drug Development

St. Jude’s Gene Therapy Appears to Cure “Bubble Boy Disease”

St. Jude Children’s Research Hospital published data from its Phase I/II clinical trial of its gene therapy for SXCID or SCID-X1, also dubbed “bubble boy disease.” The research was published in the New England Journal of Medicine.

April 18, 2019
·
2 min read
·
Mark Terry
Business

GSK Makes Cuts as It Implements New R&D Focus on Oncology, Immunology and Genetics

Since GSK initiated this new focus, the company has made several key moves to support the plan, including the December 2018 acquisition of Tesaro Oncology.

April 18, 2019
·
3 min read
·
Alex Keown
Job Trends

Life Sciences Industry Threatened by Skills Shortage

There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.

April 18, 2019
·
5 min read
·
Mark Terry
Business

Nagasaki University and NEC Establish Program on Global Health & Biometric Authentication

Contributing to the development of maternal and child health, and medical information in Kenya

April 18, 2019
·
4 min read
Deals

Pharma Biotech and Nutrition Businesses Continue to Drive Lonza Performance in Q1 2019

All investments in healthcare businesses progressing as planned to further accelerate growth

April 18, 2019
·
10 min read
Deals

Evotec Completes Repayment Of Eur 140 M Acquisition Loan

Eur 140 m bridge loan was drawn to secure evotec’s value chain expansion by successful acquisition of aptuit in august 2017

April 18, 2019
·
3 min read
Business

Sartorius Starts off Fiscal 2019 with a Strong First Quarter

Group revenue up 16.8%; order intake up 16.6%; earnings margin1) 26.2%

April 18, 2019
·
9 min read
Genetown

Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development

Financing will support Phase 3 trial of FCR001 for living donor kidney transplant patients and additional Phase 2 studies in high-need indications

April 18, 2019
·
6 min read